Gather verified email addresses & phone numbers directly from LinkedIn
202M+
Contacts
44M+
Companies
57M+
Emails
9M+
Phone numbers
Head of Early Clinical Development at Chugai Pharma USA
Professional Email
jor****@chugai-pharm.co.jp
Personal Email
****@****.com
Work Phone
+88 (622) 715*****
Mobile
+88 (622) 715*****
Local Location
Bernards, New Jersey, United States
HQ Location
japan
Website
http://www.chugai-pharm.co.jp
Industry
pharmaceuticals
Designation
Head of Early Clinical Development at Chugai Pharma USA
Birthday
-
HQ Location
japan
Industry
pharmaceutical manufacturing
Employees
241
Specialties

Install the Orion chrome extension from the Web Store. Sign up using your email address.

The Extension will sync with your LinkedIn from where you can discover in-depth Prospects' profiles, company information and Find Similar details.

Get detailed insights of Prospects Company Profile, Email ID, Phone Number, Location or Similar Designation and much more.
1
1
Number of Companies Worked For
Number of Job Titles
Joris Bie is currently employed at Chugai Pharma USA, Inc.. Joris is an experienced professional working at Chugai Pharma USA, Inc. as the Head of Early Clinical Development at Chugai Pharma USA. Joriss phone number is +88 (622) 715***** and email is jor****@chugai-pharm.co.jp to get more information install Orion extension.
Joris Bie is currently employed at Chugai Pharma USA, Inc..
At present, Joris Bie is serving as the Head of Early Clinical Development at Chugai Pharma USA.
The professional email used by Joris Bie is jor****@chugai-pharm.co.jp.
Joris Bie's professional contact number is +88 (622) 715*****.
Stephen Woolhead, Bill Berger, Caroline Germa, Pamela Zappacosta, Kevin Elliott are some of the other counterparts holding the similar designation in other organizations like Joris Bie.
Joris Bie has worked for Chugai Pharma USA, Inc.false so far.
According to the Chugai Pharma USA, Inc. Summary, Chugai’s strength in R&D and antibody technologies continues on in global efforts for products and services for the benefit of patients. Chugai Pharma USA, Inc. (CPUSA), located in Berkeley Heights, NJ, is a wholly owned subsidiary of Chugai Pharmaceutical Co., Ltd. (Chugai). CPUSA supports the planning and execution of global and U.S. clinical programs for Chugai-originated, innovative new drug candidates. Chugai is one of Japan’s leading research-based pharmaceutical companies with strengths in biotechnology products. Chugai, based in Tokyo, specializes in prescription pharmaceuticals and is listed on the 1st section of the Tokyo Stock Exchange. As an important member of the Roche Group, Chugai is actively involved in R&D activities in Japan and abroad. Specifically, Chugai is working to develop innovative products which may satisfy the unmet medical needs in Chugai’s strategic fields of oncology, bone and joint diseases, and renal diseases as well as other therapeutic areas with serious unmet needs. Chugai develops its products independently from Roche until early Proof-of-Concept (PoC) for worldwide market, including U.S. For late stage clinical development and marketing outside of Japan, South Korea, and Taiwan, Chugai seeks for partnership with Roche, which has the first refusal rights to develop/sell Chugai products, or other third parties. For a list of Chugai’s current research projects please visit: http://www.chugai-pharm.co.jp/english/ir/reports_downloads/pipeline.html.
The company is headquartered at Japan.
Joris Bie is Head of Early Clinical Development at Chugai Pharma USA at Chugai Pharma USA, Inc..
Joris Bie is currently residing in Bernards, New Jersey, United States.
Joris Bie is currently working with the pharmaceuticals industry.
Nearly 241 is the total headcount of the company.
No colleagues found